Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
about
Mutation of the INI1 gene in composite rhabdoid tumor of the endometriumATP-dependent chromatin remodeling complexes as novel targets for cancer therapySWI/SNF chromatin remodeling complexes and cancerCoordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expressionIntegrated genetic and pharmacologic interrogation of rare cancersTherapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1.Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen.Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets.Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material.The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells.Characterization of DNA binding property of the HIV-1 host factor and tumor suppressor protein Integrase Interactor 1 (INI1/hSNF5).Genome-wide approach to identify second gene targets for malignant rhabdoid tumors using high-density oligonucleotide microarrays.HIV-1 replication in cell lines harboring INI1/hSNF5 mutations.p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors.In vitro activities of novel 4-HPR derivatives on a panel of rhabdoid and other tumor cell lines.Sensitivity of malignant rhabdoid tumor cell lines to PD 0332991 is inversely correlated with p16 expression.Atypical teratoid rhabdoid tumor: current therapy and future directions.The requirement for cyclin D function in tumor maintenance.Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells.Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies.Swi/Snf chromatin remodeling/tumor suppressor complex establishes nucleosome occupancy at target promotersAn Essential Role of INI1/hSNF5 Chromatin Remodeling Protein in HIV-1 Posttranscriptional Events and Gag/Gag-Pol Stability.The role of INI1/hSNF5 in gene regulation and cancer.The role of SMARCB1/INI1 in development of rhabdoid tumor.Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome.Cell cycle proteins as promising targets in cancer therapyThrowing the cancer switch: reciprocal roles of polycomb and trithorax proteinsAtypical teratoid/rhabdoid tumor: short clinical description and insight into possible mechanism of the disease.Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer.Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.Molecular biology of pediatric brain tumors and impact on novel therapies.Biology and Treatment of Rhabdoid Tumor.Driver mutations of cancer epigenomes.Loss of CDKN1C in a Recurrent Atypical Teratoid/Rhabdoid Tumor.Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway.
P2860
Q24671688-23BBB3A5-9587-4F61-B548-67BE28EAC3B2Q26849467-D3391B6B-C134-4CF0-BC0E-145833F25880Q26998657-BC2668C7-98BF-49F6-AB2A-9932F6DED238Q28067573-858807C9-7F35-4E07-A7BF-931EF241FA47Q28829289-8CC645BF-9EF1-4E98-8286-A8B0C7250D4EQ30497840-A1B41E7F-9795-413D-9A04-D4B786664372Q33744341-3D4B50A1-DFB8-4F7D-84F8-F6AFF866C192Q33751778-C484CD0A-1A3E-4926-B249-448764F02E0AQ33844721-D9EF54FA-111D-4F1B-9B01-FC3B68CC1B7BQ34202062-D6050612-1219-4FCB-BB49-AA9E729BF737Q34332647-3E2218AE-2E95-4E00-AE66-5CC52822E8EBQ34483391-3C94DEED-B5A1-4A0D-8A10-FD8AFA50B1AEQ34771550-F787D022-9374-4ED5-9F92-D5E28AD434D8Q34825283-A030F9AF-D35B-417D-88D7-349A5C306860Q35051968-1915B303-530F-46B9-AC74-C5248B0737CDQ35069785-937CD8A2-5DFD-47A8-A117-2EA57337A8FEQ35133362-E7D6E72E-503A-4218-8297-3DA0D466AE63Q35477972-1B22AA1E-7B7B-4738-9378-BB9A83E0D149Q35545894-E4279091-7A60-48D3-9089-306E12A7C449Q36227670-D22DFFCC-8D9E-49D2-912D-201C52F41FA2Q36366702-E313646E-E277-4F0B-8A91-A3ACB3ECDBF3Q36544065-D24E8104-31BC-47E6-978E-ECBA03DCF55DQ36893203-4CB1FEB4-3984-4365-9D02-DABFF11FD70EQ36950326-76E891BB-5D0A-47FE-BA7C-9886D0EBB0D5Q37347358-FF8944D1-FC53-4C87-A5EC-0A01CF84FE4CQ37398625-983BB756-ADC2-4740-9E5A-53EA9C7D75F1Q37420245-EC4495EB-0091-4C73-9AA0-1A88BDBE62EAQ37544962-460B877C-CCAA-4171-9A52-B434A1FC4A07Q37693690-04E09B82-4876-4F4B-82CA-373C5E5894DDQ37791830-F998FD90-FE5C-40CD-BC4C-B96D2A0E50C0Q37821086-6088A077-2F96-42E5-9334-E15B1203404FQ38083797-FFDA560F-AD12-4D6F-A437-AEF59ACA75EBQ38121136-5A64E5D0-8A36-4F00-B228-99DC40735D8CQ38339385-0EB8B6AD-20BE-49B9-9572-335A5651F999Q38359284-4173F726-FC85-4491-B460-A21B6417E0F1Q38582867-FBFE38A4-E4B1-4091-9EC6-DC27F08C3CF6Q38639828-11187185-EC1B-405B-8EDF-68ACA2C9099DQ38668017-4B0D7D36-262C-4DEF-A581-3373D65B1E25Q39126217-591FB673-950A-4614-871A-1592B08463CCQ39485982-60C7DCA4-5E1F-4539-926F-EE87D34351F4
P2860
Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Genetic ablation of Cyclin D1 ...... mors resulting from Ini1 loss.
@ast
Genetic ablation of Cyclin D1 ...... mors resulting from Ini1 loss.
@en
type
label
Genetic ablation of Cyclin D1 ...... mors resulting from Ini1 loss.
@ast
Genetic ablation of Cyclin D1 ...... mors resulting from Ini1 loss.
@en
prefLabel
Genetic ablation of Cyclin D1 ...... mors resulting from Ini1 loss.
@ast
Genetic ablation of Cyclin D1 ...... mors resulting from Ini1 loss.
@en
P2093
P2860
P356
P1476
Genetic ablation of Cyclin D1 ...... mors resulting from Ini1 loss.
@en
P2093
David Zagzag
Ganjam V Kalpana
Mary Tsikitis
Winfried Edelman
Zhikai Zhang
P2860
P304
12129-12134
P356
10.1073/PNAS.0505300102
P407
P577
2005-08-12T00:00:00Z